A multisite psychotherapy and medication trial for depressed adolescents: Background and benefits

Christopher J. Kratochvil, Anne Simons, Benedetto Vitiello, John Walkup, Graham Emslie, David Rosenberg, John S. March

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The Treatment for Adolescents With Depression Study (TADS) is an NIMH-supported multisite clinical trial that compares the. effectiveness of a depression-specific cognitive behavioral therapy (CBT), medication management with fluoxetine (FLX), the combination of CBT and FLX (COMB), and medical management with pill placebo (PBO). TADS was specifically designed as a comprehensive effectiveness study, able to answer clinically meaningful questions by including a broad and representative sample of depressed teens, delivering treatment at both tertiary medical centers and community clinics, and assessing functional as well as symptomatic outcomes. This report supports the importance of conducting clinical trials in youth with depression to bridge the gap between science and practice.

Original languageEnglish (US)
Pages (from-to)159-165
Number of pages7
JournalCognitive and Behavioral Practice
Volume12
Issue number2
DOIs
StatePublished - 2005

Fingerprint

Psychotherapy
Depression
Fluoxetine
Cognitive Therapy
Clinical Trials
National Institute of Mental Health (U.S.)
Therapeutics
Placebos

ASJC Scopus subject areas

  • Psychology(all)
  • Clinical Psychology

Cite this

A multisite psychotherapy and medication trial for depressed adolescents : Background and benefits. / Kratochvil, Christopher J.; Simons, Anne; Vitiello, Benedetto; Walkup, John; Emslie, Graham; Rosenberg, David; March, John S.

In: Cognitive and Behavioral Practice, Vol. 12, No. 2, 2005, p. 159-165.

Research output: Contribution to journalArticle

Kratochvil, Christopher J. ; Simons, Anne ; Vitiello, Benedetto ; Walkup, John ; Emslie, Graham ; Rosenberg, David ; March, John S. / A multisite psychotherapy and medication trial for depressed adolescents : Background and benefits. In: Cognitive and Behavioral Practice. 2005 ; Vol. 12, No. 2. pp. 159-165.
@article{3532072364e74eef8531ed4b65bcd9a1,
title = "A multisite psychotherapy and medication trial for depressed adolescents: Background and benefits",
abstract = "The Treatment for Adolescents With Depression Study (TADS) is an NIMH-supported multisite clinical trial that compares the. effectiveness of a depression-specific cognitive behavioral therapy (CBT), medication management with fluoxetine (FLX), the combination of CBT and FLX (COMB), and medical management with pill placebo (PBO). TADS was specifically designed as a comprehensive effectiveness study, able to answer clinically meaningful questions by including a broad and representative sample of depressed teens, delivering treatment at both tertiary medical centers and community clinics, and assessing functional as well as symptomatic outcomes. This report supports the importance of conducting clinical trials in youth with depression to bridge the gap between science and practice.",
author = "Kratochvil, {Christopher J.} and Anne Simons and Benedetto Vitiello and John Walkup and Graham Emslie and David Rosenberg and March, {John S.}",
year = "2005",
doi = "10.1016/S1077-7229(05)80021-5",
language = "English (US)",
volume = "12",
pages = "159--165",
journal = "Cognitive and Behavioral Practice",
issn = "1077-7229",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - A multisite psychotherapy and medication trial for depressed adolescents

T2 - Background and benefits

AU - Kratochvil, Christopher J.

AU - Simons, Anne

AU - Vitiello, Benedetto

AU - Walkup, John

AU - Emslie, Graham

AU - Rosenberg, David

AU - March, John S.

PY - 2005

Y1 - 2005

N2 - The Treatment for Adolescents With Depression Study (TADS) is an NIMH-supported multisite clinical trial that compares the. effectiveness of a depression-specific cognitive behavioral therapy (CBT), medication management with fluoxetine (FLX), the combination of CBT and FLX (COMB), and medical management with pill placebo (PBO). TADS was specifically designed as a comprehensive effectiveness study, able to answer clinically meaningful questions by including a broad and representative sample of depressed teens, delivering treatment at both tertiary medical centers and community clinics, and assessing functional as well as symptomatic outcomes. This report supports the importance of conducting clinical trials in youth with depression to bridge the gap between science and practice.

AB - The Treatment for Adolescents With Depression Study (TADS) is an NIMH-supported multisite clinical trial that compares the. effectiveness of a depression-specific cognitive behavioral therapy (CBT), medication management with fluoxetine (FLX), the combination of CBT and FLX (COMB), and medical management with pill placebo (PBO). TADS was specifically designed as a comprehensive effectiveness study, able to answer clinically meaningful questions by including a broad and representative sample of depressed teens, delivering treatment at both tertiary medical centers and community clinics, and assessing functional as well as symptomatic outcomes. This report supports the importance of conducting clinical trials in youth with depression to bridge the gap between science and practice.

UR - http://www.scopus.com/inward/record.url?scp=32444443985&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32444443985&partnerID=8YFLogxK

U2 - 10.1016/S1077-7229(05)80021-5

DO - 10.1016/S1077-7229(05)80021-5

M3 - Article

AN - SCOPUS:32444443985

VL - 12

SP - 159

EP - 165

JO - Cognitive and Behavioral Practice

JF - Cognitive and Behavioral Practice

SN - 1077-7229

IS - 2

ER -